7,541.40

-38.67

-0.51%

51,983.98

+213.67

+0.41%

25,164.32

-272.68

-1.07%

2,805.88

-5.97

-0.21%

4.8940

-0.0350

-0.71%

21.15

+1.73

+8.91%

3,956.60

+57.70

+1.48%

76,823.25

-880.83

-1.13%

Crude Oil Dec 26

96.26

-7.86

-7.55%

US Private Equity

10,850.63

-82.20

-0.75%

LIVE It’s John Ternus’ first earnings call as Apple CEO. Listen in here.

OTC Markets OTCQX - Delayed Quote USD

Vaxart, Inc. (VXRT)

0.4075 -0.0125 (-2.98%)

At close: 3:58:51 PM EST

Loading Chart for VXRT

Chart Range Bar

Interval:

In partnership with ChartIQ

Vaxart to Host Stockholder Fireside Chat on November 6 at 4:30 p.m. ET

Vaxart to Host Stockholder Fireside Chat on November 6 at 4:30 p.m. ET

Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors

Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors

Vaxart Announces Publication of Preclinical Study Demonstrating 100% Protection Against a Lethal Dose of H5N1 Avian Flu in a Ferret Challenge Model

Vaxart Announces Publication of Preclinical Study Demonstrating 100% Protection Against a Lethal Dose of H5N1 Avian Flu in a Ferret Challenge Model

Vaxart Highlights Oral Vaccine Platform, COVID Trial Progress at H.C. Wainwright Conference

Vaxart Highlights Oral Vaccine Platform, COVID Trial Progress at H.C. Wainwright Conference

Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Vaxart Expands Intellectual Property Portfolio with European Patent Protecting Proprietary Norovirus Vaccine Technology

Vaxart Expands Intellectual Property Portfolio with European Patent Protecting Proprietary Norovirus Vaccine Technology

Vaxart Inc (VXRT) (Q2 2026) Earnings Call Highlights: Oral COVID Vaccine Shows Promise, Cash ...

Vaxart Inc (VXRT) (Q2 2026) Earnings Call Highlights: Oral COVID Vaccine Shows Promise, Cash ...

Vaxart Q2 Earnings Call Highlights

Vaxart Q2 Earnings Call Highlights

Vaxart to Host Stockholder Fireside Chat on August 7 at 4:30 p.m. ET

Vaxart to Host Stockholder Fireside Chat on August 7 at 4:30 p.m. ET

Vaxart to Participate in BTIG Biotechnology Conference 2026

Vaxart to Participate in BTIG Biotechnology Conference 2026

Vaxart Investors Reject Say-on-Pay as CEO Rules Out Reverse Split for Now

Vaxart Investors Reject Say-on-Pay as CEO Rules Out Reverse Split for Now

Mobilize your Website

View Site in Mobile | Classic

Share by: